STAMBP and melanoma: Recently, targeting of melanocytes and melanoma cells in vitro or melanotic lesions in vivo has been investigated using octapeptide derivatives of α-melanocyte-stimulating hormone (α-MSH) containing a chelator (DOTA) for radiometals such as 111indium, 67/68gallium or 90yttrium.